No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance

Active surveillance (AS) is standard of care for patients with low-risk prostate cancer (PCa), but its feasibility in intermediate-risk patients is controversial. We compared outcomes of low- and intermediate-risk patients managed with multiparametric magnetic resonance imaging (mpMRI)-supported AS...

Descripción completa

Detalles Bibliográficos
Autores principales: Cyll, Karolina, Löffeler, Sven, Carlsen, Birgitte, Skogstad, Karin, Plathan, May Lisbeth, Landquist, Martin, Haug, Erik Skaaheim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039068/
https://www.ncbi.nlm.nih.gov/pubmed/35468921
http://dx.doi.org/10.1038/s41598-022-10741-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039068/
https://www.ncbi.nlm.nih.gov/pubmed/35468921
http://dx.doi.org/10.1038/s41598-022-10741-8

Ejemplares similares